Literature DB >> 17151132

Human T-cell leukemia virus type 1 (HTLV-1) bZIP protein interacts with the cellular transcription factor CREB to inhibit HTLV-1 transcription.

Isabelle Lemasson1, Matthew R Lewis, Nicholas Polakowski, Patrick Hivin, Marie-Hélène Cavanagh, Sabine Thébault, Benoit Barbeau, Jennifer K Nyborg, Jean-Michel Mesnard.   

Abstract

The complex human T-cell leukemia virus type 1 (HTLV-1) retrovirus encodes several proteins that are unique to the virus within its 3'-end region. Among them, the viral transactivator Tax and posttranscriptional regulator Rex are well characterized, and both positively regulate HTLV-1 viral expression. Less is known about the other regulatory proteins encoded in this region of the provirus, including the recently discovered HBZ protein. HBZ has been shown to negatively regulate basal and Tax-dependent HTLV-1 transcription through its ability to interact with specific basic-leucine zipper (bZIP) proteins. In the present study, we found that HBZ reduces HTLV-1 transcription and virion production. We then characterized the interaction between HBZ and the cellular transcription factor CREB. CREB plays a critical role in Tax-mediated HTLV-1 transcription by forming a complex with Tax that binds to viral cyclic AMP-response elements (CREs) located within the viral promoter. We found that HBZ and CREB interact in vivo and directly in vitro, and this interaction occurs through the bZIP domain of each protein. We also found that CREM-Ia and ATF-1, which share significant homology in their bZIP domains with the bZIP domain of CREB, interact with HBZ-bZIP. The interaction between CREB and HBZ prevents CREB binding to the viral CRE elements in vitro and in vivo, suggesting that the reduction in HTLV-1 transcription by HBZ is partly due to the loss of CREB at the promoter. We also found that HBZ displaces CREB from a cellular CRE, suggesting that HBZ may deregulate CREB-dependent cellular gene expression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17151132      PMCID: PMC1797566          DOI: 10.1128/JVI.00480-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  59 in total

1.  The tax protein-DNA interaction is essential for HTLV-I transactivation in vitro.

Authors:  B A Lenzmeier; E E Baird; P B Dervan; J K Nyborg
Journal:  J Mol Biol       Date:  1999-08-27       Impact factor: 5.469

2.  HTLV-1 HBZ suppresses AP-1 activity by impairing both the DNA-binding ability and the stability of c-Jun protein.

Authors:  Jun Matsumoto; Takayuki Ohshima; Osamu Isono; Kunitada Shimotohno
Journal:  Oncogene       Date:  2005-02-03       Impact factor: 9.867

3.  HTLV-I associated myelopathy, a new clinical entity.

Authors:  M Osame; K Usuku; S Izumo; N Ijichi; H Amitani; A Igata; M Matsumoto; M Tara
Journal:  Lancet       Date:  1986-05-03       Impact factor: 79.321

4.  Identification of p40x-responsive regulatory sequences within the human T-cell leukemia virus type I long terminal repeat.

Authors:  J Brady; K T Jeang; J Duvall; G Khoury
Journal:  J Virol       Date:  1987-07       Impact factor: 5.103

5.  The bZIP transcription factor ATFx binds human T-cell leukemia virus type 1 (HTLV-1) Tax and represses HTLV-1 long terminal repeat-mediated transcription.

Authors:  Eva Forgacs; Saurabh K Gupta; Julie A Kerry; O John Semmes
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

6.  Activation of HTLV-I gene transcription by protein tyrosine phosphatase inhibitors.

Authors:  Mélanie Langlois; Brigitte Audet; Eric Legault; Marie-Eve Paré; Michel Ouellet; Jocelyn Roy; Nancy Dumais; Jean-Michel Mesnard; David M Rothstein; Susan J Marriott; Michel J Tremblay; Benoit Barbeau
Journal:  Virology       Date:  2004-11-24       Impact factor: 3.616

7.  Characterization of cellular factors that interact with the human T-cell leukemia virus type I p40x-responsive 21-base-pair sequence.

Authors:  K T Jeang; I Boros; J Brady; M Radonovich; G Khoury
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

8.  Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis.

Authors:  A Gessain; F Barin; J C Vernant; O Gout; L Maurs; A Calender; G de Thé
Journal:  Lancet       Date:  1985-08-24       Impact factor: 79.321

9.  Silencing of human T-cell leukemia virus type I gene transcription by epigenetic mechanisms.

Authors:  Yuko Taniguchi; Kisato Nosaka; Jun-ichirou Yasunaga; Michiyuki Maeda; Nancy Mueller; Akihiko Okayama; Masao Matsuoka
Journal:  Retrovirology       Date:  2005-10-22       Impact factor: 4.602

10.  Specific TATAA and bZIP requirements suggest that HTLV-I Tax has transcriptional activity subsequent to the assembly of an initiation complex.

Authors:  Yick-Pang Ching; Abel C S Chun; King-Tung Chin; Zhi-Qing Zhang; Kuan-Teh Jeang; Dong-Yan Jin
Journal:  Retrovirology       Date:  2004-07-30       Impact factor: 4.602

View more
  93 in total

1.  The HTLV-1 hbz antisense gene indirectly promotes tax expression via down-regulation of p30(II) mRNA.

Authors:  Gunjan Choudhary; Lee Ratner
Journal:  Virology       Date:  2010-12-21       Impact factor: 3.616

Review 2.  Molecular mechanisms of HTLV-1 infection and pathogenesis.

Authors:  Junichiro Yasunaga; Masao Matsuoka
Journal:  Int J Hematol       Date:  2011-09-28       Impact factor: 2.490

3.  HBZ-mediated shift of JunD from growth suppressor to tumor promoter in leukemic cells by inhibition of ribosomal protein S25 expression.

Authors:  M Terol; H Gazon; I Lemasson; M Duc-Dodon; B Barbeau; R Césaire; J-M Mesnard; J-M Péloponèse
Journal:  Leukemia       Date:  2017-03-06       Impact factor: 11.528

4.  HTLV-1 HBZ protein deregulates interactions between cellular factors and the KIX domain of p300/CBP.

Authors:  Pamela R Cook; Nicholas Polakowski; Isabelle Lemasson
Journal:  J Mol Biol       Date:  2011-04-08       Impact factor: 5.469

5.  Human T-cell leukemia virus type 1 HBZ protein bypasses the targeting function of ubiquitination.

Authors:  Osamu Isono; Takayuki Ohshima; Yasushi Saeki; Jun Matsumoto; Makoto Hijikata; Keiji Tanaka; Kunitada Shimotohno
Journal:  J Biol Chem       Date:  2008-09-19       Impact factor: 5.157

Review 6.  Human T-lymphotropic virus proteins and post-translational modification pathways.

Authors:  Carlo Bidoia
Journal:  World J Virol       Date:  2012-08-12

7.  Suppression of HTLV-1 replication by Tax-mediated rerouting of the p13 viral protein to nuclear speckles.

Authors:  Vibeke Andresen; Cynthia A Pise-Masison; Uma Sinha-Datta; Marcia Bellon; Valerio Valeri; Robyn Washington Parks; Valentina Cecchinato; Risaku Fukumoto; Christophe Nicot; Genoveffa Franchini
Journal:  Blood       Date:  2011-06-15       Impact factor: 22.113

8.  Human T-cell leukemia virus type 2 produces a spliced antisense transcript encoding a protein that lacks a classic bZIP domain but still inhibits Tax2-mediated transcription.

Authors:  Marilène Halin; Estelle Douceron; Isabelle Clerc; Chloé Journo; Nga Ling Ko; Sébastien Landry; Edward L Murphy; Antoine Gessain; Isabelle Lemasson; Jean-Michel Mesnard; Benoît Barbeau; Renaud Mahieux
Journal:  Blood       Date:  2009-07-14       Impact factor: 22.113

Review 9.  Viruses associated with human cancer.

Authors:  Margaret E McLaughlin-Drubin; Karl Munger
Journal:  Biochim Biophys Acta       Date:  2007-12-23

10.  The four and a half LIM family members are novel interactants of the human T-cell leukemia virus type 1 Tax oncoprotein.

Authors:  Áine McCabe; Kenichi Hashimoto; William W Hall; Noreen Sheehy
Journal:  J Virol       Date:  2013-04-24       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.